Protalix BioTherapeutics
PLX
#8340
Rank
โ‚น19.33 B
Marketcap
โ‚น240.48
Share price
-5.76%
Change (1 day)
18.03%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.84. In 2024 the company made an earnings per share (EPS) of โ‚น3.67 a decrease over its 2023 EPS that were of โ‚น11.01.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-52.47%
2024โ‚น3.67-66.67%
2023โ‚น11.01-138.71%
2022-โ‚น28.45-50%
2021-โ‚น56.91181.82%
2020-โ‚น20.19-82.11%
2019-โ‚น112.90-31.67%
2018-โ‚น165.22-72.31%
2017-โ‚น596.61124.14%
2016-โ‚น266.18-147.54%
2015โ‚น559.90-290.63%
2014-โ‚น293.726.67%
2013-โ‚น275.36130.77%
2012-โ‚น119.32-69.77%
2011-โ‚น394.6819.44%
2010-โ‚น330.43-12.2%
2009-โ‚น376.3336.67%
2008-โ‚น275.36-37.5%
2007-โ‚น440.5850%
2006-โ‚น293.723.23%
2005-โ‚น284.54138.46%
2004-โ‚น119.32-74%
2003-โ‚น458.93-0%
2002-โ‚น458.93-50%
2001-โ‚น917.87233.33%
2000-โ‚น275.36-84.21%
1999-โ‚น1,744-24%
1998-โ‚น2,295-600%
1997โ‚น458.93-16.67%
1996โ‚น550.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.83 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น395.60 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.10-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น113.82 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel